myc family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer.

B. E. Johnson, J. F. Brennan, D. C. Ihde, A. F. Gazdar

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The myc family DNA copy number of 291 specimens (183 tumors and 108 tumor cell lines) from patients with small-cell lung cancer has been reported in 15 different studies. Thirty-five of 108 (32%) cell lines from small-cell lung cancer patients have myc family DNA amplification (16 c-myc, 7 N-myc, and 12 L-myc). Thirty-seven of 183 (20%) tumors from patients with small-cell lung cancer have myc family DNA amplification (3 c-myc, 13 N-myc, and 18 L-myc). The myc family DNA copy number in tumors from patients with small-cell lung cancer is similar in the majority of sites from the same patient. The presence of myc family DNA amplification in the tumor cell line is also typically present in the tumor from the same patient. myc family DNA amplification is present in a minority of patients with small-cell lung cancer, and the data on its association with shorter survival of patients are meager at present. Future studies on the biology of the myc family in small-cell lung cancer may require use of newer technologies that can work with small tissue samples typically available at the start of therapy.

Original languageEnglish (US)
Pages (from-to)39-43
Number of pages5
JournalJournal of the National Cancer Institute. Monographs
Issue number13
StatePublished - 1992

Fingerprint

Small Cell Lung Carcinoma
Tumor Cell Line
DNA
Neoplasms
Technology
Cell Line
Survival

ASJC Scopus subject areas

  • Medicine(all)

Cite this

myc family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer. / Johnson, B. E.; Brennan, J. F.; Ihde, D. C.; Gazdar, A. F.

In: Journal of the National Cancer Institute. Monographs, No. 13, 1992, p. 39-43.

Research output: Contribution to journalArticle

@article{a87d467777224259a6255a6a0f8e4c95,
title = "myc family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer.",
abstract = "The myc family DNA copy number of 291 specimens (183 tumors and 108 tumor cell lines) from patients with small-cell lung cancer has been reported in 15 different studies. Thirty-five of 108 (32{\%}) cell lines from small-cell lung cancer patients have myc family DNA amplification (16 c-myc, 7 N-myc, and 12 L-myc). Thirty-seven of 183 (20{\%}) tumors from patients with small-cell lung cancer have myc family DNA amplification (3 c-myc, 13 N-myc, and 18 L-myc). The myc family DNA copy number in tumors from patients with small-cell lung cancer is similar in the majority of sites from the same patient. The presence of myc family DNA amplification in the tumor cell line is also typically present in the tumor from the same patient. myc family DNA amplification is present in a minority of patients with small-cell lung cancer, and the data on its association with shorter survival of patients are meager at present. Future studies on the biology of the myc family in small-cell lung cancer may require use of newer technologies that can work with small tissue samples typically available at the start of therapy.",
author = "Johnson, {B. E.} and Brennan, {J. F.} and Ihde, {D. C.} and Gazdar, {A. F.}",
year = "1992",
language = "English (US)",
pages = "39--43",
journal = "NCI Monographs",
issn = "1052-6773",
publisher = "Oxford University Press",
number = "13",

}

TY - JOUR

T1 - myc family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer.

AU - Johnson, B. E.

AU - Brennan, J. F.

AU - Ihde, D. C.

AU - Gazdar, A. F.

PY - 1992

Y1 - 1992

N2 - The myc family DNA copy number of 291 specimens (183 tumors and 108 tumor cell lines) from patients with small-cell lung cancer has been reported in 15 different studies. Thirty-five of 108 (32%) cell lines from small-cell lung cancer patients have myc family DNA amplification (16 c-myc, 7 N-myc, and 12 L-myc). Thirty-seven of 183 (20%) tumors from patients with small-cell lung cancer have myc family DNA amplification (3 c-myc, 13 N-myc, and 18 L-myc). The myc family DNA copy number in tumors from patients with small-cell lung cancer is similar in the majority of sites from the same patient. The presence of myc family DNA amplification in the tumor cell line is also typically present in the tumor from the same patient. myc family DNA amplification is present in a minority of patients with small-cell lung cancer, and the data on its association with shorter survival of patients are meager at present. Future studies on the biology of the myc family in small-cell lung cancer may require use of newer technologies that can work with small tissue samples typically available at the start of therapy.

AB - The myc family DNA copy number of 291 specimens (183 tumors and 108 tumor cell lines) from patients with small-cell lung cancer has been reported in 15 different studies. Thirty-five of 108 (32%) cell lines from small-cell lung cancer patients have myc family DNA amplification (16 c-myc, 7 N-myc, and 12 L-myc). Thirty-seven of 183 (20%) tumors from patients with small-cell lung cancer have myc family DNA amplification (3 c-myc, 13 N-myc, and 18 L-myc). The myc family DNA copy number in tumors from patients with small-cell lung cancer is similar in the majority of sites from the same patient. The presence of myc family DNA amplification in the tumor cell line is also typically present in the tumor from the same patient. myc family DNA amplification is present in a minority of patients with small-cell lung cancer, and the data on its association with shorter survival of patients are meager at present. Future studies on the biology of the myc family in small-cell lung cancer may require use of newer technologies that can work with small tissue samples typically available at the start of therapy.

UR - http://www.scopus.com/inward/record.url?scp=0026494173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026494173&partnerID=8YFLogxK

M3 - Article

C2 - 1327035

AN - SCOPUS:0026494173

SP - 39

EP - 43

JO - NCI Monographs

JF - NCI Monographs

SN - 1052-6773

IS - 13

ER -